Prevalence, structure, frequency of complications and outcomes of treatment of rhabdomyolysis in acute exogenous intoxication in a multidisciplinary hospital

Cover Page

Cite item

Full Text

Abstract

Introduction. The prevalence of rhabdomyolysis among people admitted to the hospital due to acute poisoning reaches, according to various foreign sources, from 30 to 40%. In 60% of cases, the development of rhabdomyolysis in adult patients is associated with acute exogenous intoxication. Currently, data on the prevalence, structure and outcomes of treatment of rhabdomyolysis in toxicological patients are mainly presented by the results of foreign clinical and epidemiological studies.

The aim is to study the prevalence, structure, frequency of complications and outcomes of treatment of rhabdomyolysis in acute exogenous intoxication in a multidisciplinary hospital.

Material and methods. The study included 1,363 patients who were treated from 2017 to 2020 with acute exogenous intoxication. During the study, 98 patients with rhabdomyolysis were selected from the general group. The frequency of poisoning with various toxicants was analyzed, the effects of which led to the development of rhabdomyolysis in acute exogenous intoxication. The incidence of acute kidney injury (AKI) was detected, the outcomes of acute poisoning treatment, the duration of inpatient treatment were determined, and a comparative analysis was carried out between groups of patients with rhabdomyolysis in acute exogenous intoxication (n=98) and without it (n=1265).

Results. The prevalence of rhabdomyolysis among patients hospitalized for acute poisoning was 7%. The main reason for the development of rhabdomyolysis was the use of narcotic drugs — 87% of cases. The development of rhabdomyolysis in acute exogenous intoxication in 59.2% of cases is accompanied by the occurrence of AKI, which is significantly higher than among patients without rhabdomyolysis (11.6%). The occurrence of rhabdomyolysis in toxicological patients increases hospital mortality from 6.1 to 10.2%, as well as the duration of inpatient treatment and intensive care by 5.2 and 3.3 days, respectively.

Limitations. The study was conducted based on only one multidisciplinary hospital in Moscow in the period from 2017 to 2020.

Conclusion. Rhabdomyolysis is a serious complication of acute poisoning, the development of which significantly worsens the outcomes of treatment of patients with a toxicological profile, which requires the development of effective methods for the prevention, diagnosis and treatment of rhabdomyolysis in acute exogenous intoxication.

Compliance with ethical standards. The study does not require the submission of the conclusion of the biomedical ethics committee.

Author contribution:
Masolitin S.V. — concept and design of the study, collection and processing of material, statistical analysis, writing the text of the article;
Kim V.G., Magomedov M.A. — collection and processing of material;
Marukhov A.V., Chubchenko N.V. — statistical analysis, editing the text of the article;
Protsenko D.N., Tyurin I.N., Mamontova O.A. — editing the text of the article.
All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.

Conflict of interests. The authors declare no conflict of interest. 

Funding. The study was not sponsored.

Received: February 28, 2022 / Accepted: December 12, 2022 / Published: December 30, 2022

About the authors

Sergey Viktorovich Masolitin

City Clinical Hospital No. 1 named after N.I. Pirogov of the Department of Healthcare of the City of Moscow

Author for correspondence.
Email: ser.kot.2010@mail.ru
ORCID iD: 0000-0002-6809-6163

Врач анестезиолог реаниматолог отделения реанимации и интенсивной терапии № 1 ГБУЗ «Городская клиническая больница № 1 им. Н.И. Пирогова Департамента здравоохранения города Москвы», 119049, г. Москва, Российская Федерация.

e-mail: ser.kot.2010@mail.ru 

Russian Federation

Denis Nikolaevich Protsenko

City Clinical Hospital No. 40 of the Department of Healthcare of the City of Moscow; FSBE HE N.I. Pirogov RNRMU MOH Russia

Email: drprotsenko@me.com
ORCID iD: 0000-0002-5166-3280

Кандидат медицинских наук, главный врач Городской клинической больницы № 40 Департамента здравоохранения Москвы, 129301, г. Москва, Российская Федерация; заведующий кафедрой анестезиологии и реаниматологии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, 117997, г. Москва, Российская Федерация.

e-mail: drprotsenko@me.com 

Russian Federation

Igor' Nikolaevich Tyurin

City Clinical Hospital No. 40 of the Department of Healthcare of the City of Moscow; FSBE HE N.I. Pirogov RNRMU MOH Russia

Email: mma16@bk.ru
ORCID iD: 0000-0002-5696-1586

Кандидат медицинских наук, доцент кафедры анестезиологии и реаниматологии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, 117997, г. Москва, Российская Федерация; заместитель главного врача по медицинской части в ГБУЗ «Городская клиническая больница № 40», 129301, Москва, Российская Федерация.

e-mail: mma16@bk.ru 

Russian Federation

Ol'ga Alekseevna Mamontova

FSBE HE N.I. Pirogov RNRMU MOH Russia

Email: afdpo@bk.ru
ORCID iD: 0000-0003-4742-7274

Кандидат медицинских наук, доцент кафедры анестезиологии и реаниматологии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, 117997, г. Москва, Российская Федерация.

e-mail: afdpo@bk.ru 

Russian Federation

Marat Adessovich Magomedov

City Clinical Hospital No. 1 named after N.I. Pirogov of the Department of Healthcare of the City of Moscow; FSBE HE N.I. Pirogov RNRMU MOH Russia

Email: noemail@neicon.ru
ORCID iD: 0000-0002-1972-7336

Кандидат медицинских наук, заместитель главного врача по анестезиологии и реаниматологии ГБУЗ «Городская клиническая больница № 1 им. Н.И. Пирогова Департамента здравоохранения города Москвы», 119049, г. Москва, Российская Федерация; ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, 117997, г. Москва, Российская Федерация.

e-mail: mma16@bk.ru 

Russian Federation

Timur Gennadievich Kim

City Clinical Hospital No. 1 named after N.I. Pirogov of the Department of Healthcare of the City of Moscow

Email: frack_@mail.ru
ORCID iD: 0000-0003-0159-2493

Заведующий отделением реанимации и интенсивной терапии № 1 ГБУЗ «Городская клиническая больница № 1 им. Н.И. Пирогова Департамента здравоохранения города Москвы», 119049, г. Москва, Российская Федерация.

e-mail: frack_@mail.ru 

Russian Federation

Artem Vladimirovich Marukhov

Military Medical Academy named after S.M. Kirov

Email: noemail@neicon.ru
ORCID iD: 0000-0003-2673-8081

Кандидат медицинских наук, начальник отделения реанимации и интенсивной терапии № 1 клиники нефрологии и эфферентной терапии ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» Министерства обороны Российской Федерации, 194044, г. Санкт-Петербург, Российская Федерация.

e-mail: frack_@mail.ru 

Russian Federation

Natal'ya Valer'evna Chubchenko

Military Medical Academy named after S.M. Kirov

Email: nchubchenko@mail.ru
ORCID iD: 0000-0002-3426-3576

Anesthesiologist-resuscitator of the resuscitation and intensive care unit No. 2 of the clinic of nephrology and efferent therapy of Military Medical Academy named after S.M. Kirov, 194044, Saint-Petersburg, Russian Federation.

e-mail: nchubchenko@mail.ru

Russian Federation

References

  1. Bel’skikh A.N., Zakharov M.V., Marukhov A.V., Korol’kov O.N. Comparison effectiveness of the of extracorporeal detoxification methods in the treatment of post-load rhabdomyolysis complicated by acute renal damage. Voenno-meditsinskiy zhurnal. 2019; 6(340): 49–54. (in Russian)
  2. Michelsen J., Cordtz J., Liboriussen L., Behzadi, M., Ibsen M., Damholt M.B. et al. Prevention of rhabdomyolysis-induced acute kidney injury – A DASAIM/DSIT clinical practice guideline. Acta Anaesthesiol Scand. 2019; 63(5): 576–86. https://doi.org/10.1111/aas.13308
  3. Ahmad S., Anees M., Elahi I., Fazal-E-Mateen. Rhabdomyolysis Leading to Acute Kidney Injury. J Coll Physicians Surg Pak. 2021; 31(2): 235–7. https://doi.org/10.29271/jcpsp.2021.02.235
  4. Debelmas A., Benchetrit D., Galanaud D., Khonsari R.H. Case 251: Nontraumatic Drug-associated Rhabdomyolysis of Head and Neck Muscles. Radiology. 2018; 286(3): 1088–92. https://doi.org/10.1148/radiol.2018152594
  5. Waldman W., Sein Anand J., Kabata P. The characteristics and outcomes of toxin-induced massive rhabdomyolysis. Int J Occup Med Environ Health. 2020; 33(5): 661–73. https://doi.org/10.13075/ijomeh.1896.01532
  6. Oshima Y. Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug Administration. Intern Med. 2011; 50(8): 845–53. https://doi.org/10.2169/internalmedicine.50.4484
  7. Cabral B.M.I., Edding S.N., Portocarrero J.P., Lerma E.V. Rhabdomyolysis. Dis Mon. 2020; 66(8): 101015. https://doi.org/10.1016/j.disamonth.2020.101015

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Masolitin S.V., Protsenko D.N., Tyurin I.N., Mamontova O.A., Magomedov M.A., Kim T.G., Marukhov A.V., Chubchenko N.V.



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 81728 от 11 декабря 2013.